medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2017, Number 2

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2017; 34 (2)

Coccidioidomicosis en el embarazo y periodo perinatal

Cano-Rangel MA, Vázquez-Alvarado JÁ, Vázquez-Ramírez FJ, Tapia-Torres CM, Mateo-Madrigal VY

Language: Spanish
References: 34
Page: 109-118
PDF size: 270.33 Kb.


ABSTRACT

The states of California and Arizona have reported an increase in Coccidioidomycosis. In Sonora, Coccydiodomicosis has a bioclimatic pattern and, since it’s not a disease for which a report is obligatory, we do not have conclusive data, except for case reports and epidemiologic studies.
According to our bibliography, the immune system undergoes a series of changes during pregnancy, that allow for the survival and development of the fetus, also making the mother more susceptible to infections of Coccidioides spp, with the possibility to vertically transmit the disease, although, rarely.
This article, seeks to establish the risks of the pregnant woman when acquiring an infection by Coccidioides spp, the complications arising with antifungal treatment and the alternatives according to the gestational age.


REFERENCES

  1. Cano MA, Álvarez G, Durazo MA, Peralta I. Coccidioidomicosis pulmonar: 24 años de experiencia en el Hospital Infantil del Estado de Sonora. Rev Mex Pediatr. 2008; 75 (4): 162-167.

  2. Mendoza MA, Acuña KM, Álvarez HG, Cano RMA, Castillo OG, Dórame CR, et al. Guía del Grupo Mexicano de Diagnóstico y Tratamiento de la Coccidioidomicosis. Enf Inf Microbiol. 2015; 35 (1): 18-31.

  3. Negroni R. Historia del descubrimiento de la coccidioidomicosis. Rev Argent Dermatosifilol. 2011; 92 (3).

  4. Hirschmann J. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis. 2007; 44 (9): 1202-1207.

  5. Barbee RA, Hicks MJ, Grosso D, Sandel C. The maternal immune response in coccidioidomycosis. Is pregnancy a risk factor for serious infection? Chest. Sep 1991; 100 (3): 709-715.

  6. Reyes MM, Pérez HM, Ocaña MJ, Frías LM, Martínez HE, Arenas R, et al. BMC Infect Dis. 2016; 16: 550.

  7. Lee CY, Thompson III GR, Hatsey CJ, Hodge GC, Lunetta JM, Pappagianis D, et al. Coccidioides endospores and spherules draw strong chemotactic, adhesive, and phagocytic responses by individual human neutrophils. PLoS One. Jun 2015; 10 (6).

  8. Duarte E, Frías MG, Zúñiga G, Martínez E, Acosta G, Reyes M. Molecular markers in the epidemiology and diagnosis of coccidioidomycosis. Rev Iberoam Micol. Jan-Mar 2014; 31 (1): 49-53.

  9. Castañón OL, Laniado LR, Concepción T, Muñoz HB, Aroch CA, Aranda UIS, et al. Clinical comparison of two coccidioidins. Mycopathologia. Jun 2010; 169 (6): 427- 430.

  10. Baptista RC, Riquelme M. Epidemiología de la coccidioidomicosis en México. Rev Iberoam Micol. 2007; 24: 100-105.

  11. Cano MA, Dórame R, Gómez N, Contreras J. Coccidioidomicosis diseminada con afección a nódulos linfáticos: Experiencia en el Hospital Infantil del Estado de Sonora (1983-2004). Bol Clin Hosp Infant Edo Son. 2006; 23 (1): 10-14.

  12. Bercovitch R, Catanzaro A, Schwartz B, Pappagianis D, Watts D, Ampel N. Coccidioidomycosis during preg nancy: a review and recommendations for management. Clin Infect Dis. Aug 2011; 53 (4): 363-368.

  13. Cohen R, Burnip R. Coccidioidin skin testing during pregnancy and in infants and children. Calif Med. Jan 1950; 72 (1): 31-33.

  14. Kourtis A, Read J, Jamieson D. Pregnancy and Infection. N Engl J Med. 2014; 370: 2211-2216.

  15. Labarca M, Santos J, Aragón J, Reyna E. Coccidioidomicosis diseminada y embarazo. Reporte de un caso. Clin Invest Ginecol Obstet. Jan-March 2015; 42 (1): 38- 40.

  16. Spinello I, Johnson R. A 19-year-old pregnant woman with a skin lesion and respiratory failure. Chest. Aug 2006; 130 (2): 611-615.

  17. Stevens D. Current concepts: Coccidioidomycosis. N Eng J Med. Apr 1995; 332 (16):1077-1082.

  18. Hooper J, Lu Q, Pepkowitz S. Sisseminated coccidioidomycosis in pregnancy. Arch Pathol Lab Med. Apr 2007; 131 (4): 652-655.

  19. Powell B, Drutz D, Huppert M, Sun S. Relationship of progesterone- and estradiol-binding proteins in Coccidoiodes immitis to coccidioidal dissemination in pregnancy. Infect Immun. May 1983; 40 (2): 478-485.

  20. Spinello I, Johnson R, Bagi S. Coccidioidomycosis and pregnancy: a review. Ann N Y Acad Sci. Sep 2007; 1111: 358-364.

  21. Arnold CA, Rakheja D, Arnold MA, Peters JM, Fernandes NJ, Quintanilla NM, et al. Unsuspected, disseminated coccidioidomycosis without maternofetal morbidity diagnosed by placental examination: case report and review of the literature. Clin Infect Dis. Jun 2008; 46 (11): e119-123.

  22. Calderón A. Características clinicopatológicas y distribución del número de autopsias de pacientes fallecidos por coccidioidomicosis en un hospital de referencia del noreste de México. Gac Med Méx 2004; 140 (4).

  23. Mathisen G, Shelub A, Truong J, Wigen C. Coccidioidal meningitis: clinical presentation and management in the fluoconazole era. Medicine (Baltimore). Sep 2010; 89 (5): 251-284.

  24. Fajardo F, Olivas M, Castillo J. Coccidioidomicosis pulmonar en un neonato. Reporte de un caso. Bol Clin Hosp Infant Edo Son. 2014; 31 (1): 57-62

  25. Tuarog M, Thompson G. Coccidioidomycosis: Recent updates. Semin Respir Crit Care Med. Oct 2015; 36 (5): 746-755.

  26. Carrada T. Los métodos de laboratorio en el diagnóstico de coccidioidomicosis. Rev Chilena Infectol. 2014; 31 (3): 293-297.

  27. Saoubolle M. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann N Y Acad Sci. Sep 2007; 1111: 301-314.

  28. Muñoz B, Palma G, Cabello C, Martínez MA. Parasitic polymorphism of Coccidioides spp. BMC Infect Dis. Apr 2014; 14: 213.

  29. Kappel S, Wu J, Hillman J, Linden K. Histopathologic findings of disseminated coccidioidomycosis with hyphae. Arch Dermatol. Apr 2007; 143 (4): 548-549.

  30. Malo J, Luraschi-Monjagatta C, Wolk D, Thompson R, Hage C. Update on the diagnosis of pulmonary coccidioidomycosis. Ann Am Thorac Soc. 2014; 11 (2): 243- 253.

  31. Blair J, Coakley B, Santelli A, Hentz J. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006; 162: 317–324.

  32. Gago S, Buitrago MJ, Clemons K, Cuenca-Estrella M, Mirels L, Stevens D. Development and Validation of a quantitative real-time PCR assay for the early diagnosis of coccidioidomycosis. Diagn Microbiol Inf Dis. Jun 2014; 79 (2): 214-221.

  33. Galgiani JN. Ampel NM, Catanzaro A, Johnson RH, Steven DA, Williams PL. Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis. 2000; 30 (6): 58-61.

  34. Galgiani J, Ampel N, Blair J, Catanzaro A, Geertsma F, Hoover S, et al. 2016 Infectous Diseases Society of America (IDSA) Clinical Practice Guidelines for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016; 63 (6): 717-722.




2020     |     www.medigraphic.com